ArticleWorld journal of clinical oncology2024
Paclitaxel for second-line treatment of squamous cell carcinoma of the head and neck: A multicenter retrospective Italian study.
Morena Fasano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.